Lung cancer
A study to assess the safety and effectiveness of a novel treatment regimen for advanced lung cancer with an uncommon genetic mutation
Who can joinAsk the trial team
AgeAsk the trial team
Kind of studyPhase 2: does it work?
What it testsA medicine
The full list of who can and cannot join is on the registry. Ask the trial team, or write to us and we will explain it in simple words.
Contact hospital
The registry names this hospital as the trial's main contact. Ask them which hospitals are taking patients.
Christian Medical College, Vellore, IndiaVelloreDirections ↗
Registry summary (technical)
Carboplatin, Pemetrexed with Cetuximab for Advanced Non-Small cell lung cancer with EGFR exon 20 insertion â?? A Multi-centric Prospective Phase II trial - CATCH20
Sponsor: Christian Medical College, Vellore
CTRI/2024/08/072275 on CTRI, India's trial registry
Source: Clinical Trials Registry – India (CTRI), via WHO ICTRP, data of 12 Oct 2026
Last updated on the registry 3 Aug 2026 · read by us 5 Nov 2026